|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,900.00 INR | -2.39% |
|
+5.11% | -20.62% |
| 17/05 | Hester Biosciences Limited, Q4 2025 Earnings Call, May 09, 2025 | |
| 09/05 | Hester Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Veterinary Drugs
| Capi. | Sales growth | Profitability (Composite) | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
| 19Cr | - | - | - | - | - | |
| 6.68TCr | ||||||
| 742.98Cr | - | |||||
| 370.96Cr | ||||||
| 344.53Cr | ||||||
| 233.22Cr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition